← All diseases Brain and nervous system

Multiple sclerosis (progressive)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (104)Meta-analysis (24)Treatment guideline (1)Randomized trial (43)Systematic review (21)Phase 3 Study (15)Clinical trial (370)Review article (234)Early study (phase 1 or 2) (22)Case report (83)Laboratory or animal study (21)Commentary or editorial (19) Studies currently recruiting participants only (33)

Filter

Publications and studies (1542)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Hydroxychloroquine in Primary Progressive Multiple Sclerosis (2021-07-30) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sunphenon in Progressive Forms of Multiple Sclerosis (2021-07-29) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety Study of Human Neural Stem Cells Injections for Secondary Progressive Multiple Sclerosis Patients (2021-07-12) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy of Early Harvest Olive Oil in Cognition of Primary (PPMS) or Secondary (SPMS) Progressive Multiple Sclerosis (2021-07-09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS (2021-07-09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Life-Style Exercise and Activity Package for People Living With Progressive MS (2021-07-02) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Idebenone for Primary Progressive Multiple Sclerosis (2021-05-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple Sclerosis (2021-05-18) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cortical Lesions in Patients With Multiple Sclerosis (2021-04-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis (2021-03-30) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis (2021-03-10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Patient Research Cohort: Rapidly Evolving Multiple Sclerosis (2021-03-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis (2021-03-03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety Study of GNbAC1 in Multiple Sclerosis Patients (2021-02-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography (2021-01-22) ♡
• Aryl Hydrocarbon Receptor Plasma Agonist Activity Correlates With Disease Activity in Progressive MS. (2020/12/24) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. HDAC6 in Diseases of Cognition and of Neurons. (2020/12/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Concurrent Resistance and Aerobic Training Regulate Adiponectin Expression and Disease Severity in Multiple Sclerosis: A Case Study. (2020/12/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunopathogenesis and Cellular Interactions in Human T-Cell Leukemia Virus Type 1 Associated Myelopathy/Tropical Spastic Paraparesis. (2020/12/22) ♡
• Progressive Loss of Corneal and Retinal Nerve Fibers in Patients With Multiple Sclerosis: A 2-Year Follow-up Study. (2020/12/21) ♡
• Primary Progressive Multiple Sclerosis Under Anti-TNFα Treatment: A Case Report. (2020/12/20) ♡
• The risk of polypharmacy, comorbidities and drug-drug interactions in women of childbearing age with multiple sclerosis. (2020/12/19) ♡
• Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years. (2020/12/18) ♡
• Epigenetic differences at the HTR2A locus in progressive multiple sclerosis patients. (2020/12/17) ♡
• Teriflunomide Safety and Efficacy in Advanced Progressive Multiple Sclerosis. (2020/12/17) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Epstein-Barr Virus and Multiple Sclerosis. (2020/12/17) ♡
• New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab. (2020/12/17) ♡
• Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis. (2020/12/16) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 1. (2020/12/16) ♡
• Tolerogenic nanoparticles suppress central nervous system inflammation. (2020/12/15) ♡
• Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAE. (2020/12/15) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 1: From the National Multiple Sclerosis Society Case Conference Proceedings. (2020/12/15) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 2: From the National Multiple Sclerosis Society Case Conference Proceedings. (2020/12/15) ♡
• Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale. (2020/12/08) ♡
• Physical activity monitoring to assess disability progression in multiple sclerosis. (2020/12/07) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Mesenchymal stem cell-derived neural progenitors in progressive MS: Two-year follow-up of a phase I study. (2020/12/04) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PML. (2020/12/03) ♡
• Prediction of disease progression and outcomes in multiple sclerosis with machine learning. (2020/12/03) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Ozanimod to Treat Relapsing Forms of Multiple Sclerosis: A Comprehensive Review of Disease, Drug Efficacy and Side Effects. (2020/12/03) ♡
• High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice. (2020/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of glycogen synthase kinase 3 beta in multiple sclerosis. (2020/12/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis. (2020/12/01) ♡
• Effects of Massage Therapy on Multiple Sclerosis: a Case Report. (2020/12/01) ♡
• Differentiation of relapsing-remitting and secondary progressive multiple sclerosis: a magnetic resonance spectroscopy study based on machine learning. (2020/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metal Imbalance in Neurodegenerative Diseases with a Specific Concern to the Brain of Multiple Sclerosis Patients. (2020/11/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Extracellular Vesicles in Demyelination of the Central Nervous System. (2020/11/30) ♡
• JC Virus Seroprevalence and JCVAb Index in Polish Multiple Sclerosis Treatment-Naïve Patients. (2020/11/27) ♡
• Multiple Sclerosis in a Multi-Ethnic Population in Houston, Texas: A Retrospective Analysis. (2020/11/25) ♡
• Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis. (2020/11/25) ♡
• Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple Sclerosis. (2020/11/20) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.